Addition of rituximab did not significantly affect OS but did show a possible trend toward improved survival especially in the older patient groups ( Supplemental Material on prognostic factors).
← all excerpts
Treatment of sporadic Burkitt lymphoma in adults, a retrospective comparison of four treatment regimens.
1
—
—